相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial
Hirotaka Miyashita et al.
SUPPORTIVE CARE IN CANCER (2021)
Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline
Philip J. Saylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The skeletal impact of cancer therapies
Lucia Bedatsova et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Metastatic bone disease: Pathogenesis and therapeutic options Up-date on bone metastasis management
Stella D'Oronzo et al.
JOURNAL OF BONE ONCOLOGY (2019)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Ten-year experience of the multidisciplinary Osteoncology Center
Alberto Bongiovanni et al.
SUPPORTIVE CARE IN CANCER (2019)
Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer
Zachary Klaassen et al.
CANCER (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Impact of skeletal-related events on survival in patients with metastatic prostate cancer prescribed androgen deprivation therapy
KW Wong et al.
HONG KONG MEDICAL JOURNAL (2015)
Burden of skeletal-related events in prostate cancer: unmet need in pain improvement
M. S. Broder et al.
SUPPORTIVE CARE IN CANCER (2015)
Prospective Study on the Incidence of Bone Metastasis (BM) and Skeletal-Related Events (SREs) in Patients (pts) with Stage IIIB and IV Lung Cancer-CSP-HOR 13
Nobuyuki Katakami et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis
Kouji Izumi et al.
BJU INTERNATIONAL (2012)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Prognostic factors for skeletal complications from metastatic bone disease in breast cancer
Janet E. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Causes of high bone alkaline phosphatase
F. Sarac et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2007)
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease
A Berruti et al.
BRITISH JOURNAL OF CANCER (2005)
分享论文
